215-109-0 | Sigma-Aldrich

The Effective Use of Protein Kinase Inhibitors

93 95 94 90 85 99 39 39 93 82 80 109 79 76 74 89 73 82 102 109 85 71 57 104 14 1 7 60 87 1 101 97 68 120 93 80 66 100 90

The Effective Use of Protein Kinase Inhibitors

93 95 94 90 85 99 39 39 93 82 80 109 79 76 74 89 73 82 102 109 85 71 57 104 14 1 7 60 87 1 101 97 68 120 93 80 66 100 90

Understanding the Effect of Discreet PEG Linkers on ADC Structure and Binding

82 361 110 PEG24 4.0 257 66 612 77 293 135 LC-SMCC 2.7 154 109 374 125 288 138 PEG8 2.6 192 88 474 99 333 119 PEG24 2.8 215 79 555 84 272 146

LABORATORY NOTEBOOK ISSUANCE PAGE

uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 <190 1.333 m–Xylene 0.868 138–139 — 25 — — — 1.497 o–Xylene 0.87 143–145 –23 32

LABORATORY NOTEBOOK ISSUANCE PAGE

uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 <190 1.333 m–Xylene 0.868 138–139 — 25 — — — 1.497 o–Xylene 0.87 143–145 –23 32

LABORATORY NOTEBOOK ISSUANCE PAGE

uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391 Water 1 100 0 — 1 78.54 <190 1.333 m–Xylene 0.868 138–139 — 25 — — — 1.497 o–Xylene 0.87 143–145 –23 32

Product Information Sheet - A5394

Ed., Edited by H. Bergmeyer, Volume 4, 2097-2126. 17. Schultz, V. et al., Analytical Biochemistry, 215, 302 (1993).

Product Information Sheet - A6144

Ed., Edited by H. Bergmeyer, Volume 4, 2097-2126. 17. Schultz, V. et al., Analytical Biochemistry, 215, 302 (1993).

Product Information Sheet-endolyss-ro

double-distilled water; 70% acetonitrile (v/v) Gradient 40 minutes linearly 0 to 100% B Flow rate 1 ml/minute Wavelength 215 nm Fragments 5.50 min Arg(22) – Lys(23) and Arg(24) – Gln(26) 12.93 min

Product Information Sheet - SE120097

myoglobin determinations in the early diagnosis of acute myocardial infarction, Acta Medica Scand., 215(5): 417-25; (1984). 15. Sylven, C., and Bendz, R., Myoglobin, creatine kinase and its isoenzyme

Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate

500 511 84% 647 109% F 0 (Basal) 75 -- 78 -- 40 115 100% 114 90% 100 167 92% 167 89%

Protocol- EZHPYTT66K

- 40 172 70% 214 105% 100 215 71% 266 94% 500 558 83% 700 106% D 0 (Basal) 92 - 104 - 40 128 90% 145 103% 100 171 79% 201 97% 500 511 84%

Product Information Sheet - G6275

J. D. Norgaard, Histochem. Cytochem., 31, 1394 (1983). 41. N.D. Tolson et al., J. Microsc., 123, 215 (1981). 42. J.W. Slot and H.J. Geuze, J. Cell. Biol., 90, 533 (1981). 43. J. Roth, Techniques in

Protocol: GyroMark™ HT Human Insulin Gyros GyrolabTM xP Workstation Assay

6250 6376 6525 102 25000 25126 22654 90 Plasma 3 Neat 118 118 98 215 205 95 391 508 538 106 1563 1680 1825 109 6250 6368 6516 102 25000 25118

Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma

IPI00478493 HP protein 273 8 168 5 374 8 IPI00430808 Hypothetical protein 179 3 217 3 2071 3 215 2 207 3 257 3 483 5 IPI00399007 Hypothetical protein DKFZp 250 4 269 3 274 5 347 4

S&E Campaign Lab Tools - Tables for laboratory use

86.18 1,376 55 – 62 160 – 190 0.32 (20°C) 0.27 2.0 0 0.09 12.5 13.9 14.6 195 104335 – Isooctane 0.4 114.23 1,392 99.2 51 0.51 0.50 1.9 0 0.01 7.9 8.3 8.7 215 104717 104718 Toluene 2.3 92.14 1,496 110.6

Product Information - H3278